You are here

Allergan

What's next for embattled Allergan? Depends on pipeline performance, analysts say

What's next for embattled Allergan? Depends on pipeline performance, analysts say

Fierce Pharma

Flag link:

Allergan (AGN) Presents Positive Data on Glaucoma Candidate

Allergan (AGN) Presents Positive Data on Glaucoma Candidate

Yahoo/Zacks.com

Open-Angle Glaucoma

ocular hypertension

Flag link:

Allergan: Restasis Lawsuit From Kroger, Walgreens Could Cost Billions

Allergan: Restasis Lawsuit From Kroger, Walgreens Could Cost Billions

NY Shock Exchange

Flag link:

Old CEO, new chairman? Some Allergan investors want Pyott to come back: report

Old CEO, new chairman? Some Allergan investors want Pyott to come back: report

Fierce Pharma

Flag link:

Allergan's Migraine Prevention Drug Meets Primary Endpoints in Ph Iib/III Study

Allergan's Migraine Prevention Drug Meets Primary Endpoints in Ph Iib/III Study

CP Wire

Flag link:

Notorious activist investor Carl Icahn buys small stake in Allergan

Notorious activist investor Carl Icahn buys small stake in Allergan

Endpoints

Flag link:

Allergan's tribal licensing deal, opposed by tech giants, gets appeals court scrutiny

Allergan's tribal licensing deal, opposed by tech giants, gets appeals court scrutiny

Fierce Pharma

Flag link:

How Allergan went from a tiny but beloved Southern California eye care company to a dealmaking machine to falling out of grace with investors (AGN)

How Allergan went from a tiny but beloved Southern California eye care company to a dealmaking machine to falling out of grace with investors (AGN)

Business Insider

Flag link:

FDA stalls yet another Herceptin copycat, issuing response letter to Amgen/Allergan

FDA stalls yet another Herceptin copycat, issuing response letter to Amgen/Allergan

Endpoints

complete response letter

Flag link:

Allergan plans sales of women's health, infectious disease units

Allergan plans sales of women's health, infectious disease units

Reuters

infectious diseases

Flag link:

Allergan recalls birth-control pill packs with out-of-order placebos

Allergan recalls birth-control pill packs with out-of-order placebos

Stat

birth control pill

Flag link:

Top research execs from Teva, Allergan recruited to help lead Axovant out of the R&D wasteland

Top research execs from Teva, Allergan recruited to help lead Axovant out of the R&D wasteland

Endpoints

Axovant Sciences

Teva Pharmaceutical

Flag link:

Tribe taking steps to ‘ramp up’ drug patent business

Tribe taking steps to ‘ramp up’ drug patent business

Drug Delivery Business News

Native Americans

Flag link:

Watch out, Allergan. Activist investor David Tepper won approval to push a shake-up

Watch out, Allergan. Activist investor David Tepper won approval to push a shake-up

Fierce Pharma

Flag link:

Allergan faces fresh woes with Restasis patents as Walgreen, retailers file lawsuit over ‘anticompetitive conduct’

Allergan faces fresh woes with Restasis patents as Walgreen, retailers file lawsuit over ‘anticompetitive conduct’

Endpoints

Flag link:

FDA stiff arms Evolus’ rival to Allergan’s blockbuster Botox, but execs promise a snap response

FDA stiff arms Evolus’ rival to Allergan’s blockbuster Botox, but execs promise a snap response

Endpoints

Flag link:

Allergan's Botox sets its sights on a new customer: men

Allergan's Botox sets its sights on a new customer: men

Medical Marketing and Media

DTC advertising

Flag link:

Allergan touts 5-year data for Liletta intrauterine contraceptive

Allergan touts 5-year data for Liletta intrauterine contraceptive

Drug Delivery Business News

Flag link:

Saunders: All options remain on the table for Allergan

Saunders: All options remain on the table for Allergan

Biopharma Dive

Flag link:

Allergan: Q1 Results Could Convince Bulls Growth Is Dead

Allergan: Q1 Results Could Convince Bulls Growth Is Dead

Seeking Alpha

Flag link:

Pages